3DBio: 3DBio Therapeutics conducts human ear reconstruction using 3D-bioprinted living tissue implant in First-in-Human clinical trial

The company stated that in addition to the Microtia-Congenital Ear Deformity Institute, the AuriNovo Phase 1/2a clinical trial is enrolling patients at Cedars-Sinai Medical Center in Los Angeles, CA under the direction of John Reinisch, M.D., Director of Craniofacial and Pediatric Plastic Surgery.